United Therapeutics (UTHR) Settles Litigation And Resets Pulmonary Hypertension Competition
United Therapeutics and Liquidia Just Ended Their Patent War. Liquidia Stock Popped 42%
This Biotech Stock Surges 29% on Patent Settlement. ‘Better Than the Best-Case Scenario.’
LQDA Explodes After Hours On Deal Ending Years Of Patent Fight, Keeping YUTREPIA On Market
Loading...